Načítá se...
Designing Nanoconjugates to Effectively Target Pancreatic Cancer Cells In Vitro and In Vivo
BACKGROUND: Pancreatic cancer is the fourth leading cause of cancer related deaths in America. Monoclonal antibodies are a viable treatment option for inhibiting cancer growth. Tumor specific drug delivery could be achieved utilizing these monoclonal antibodies as targeting agents. This type of desi...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Public Library of Science
2011
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3124468/ https://ncbi.nlm.nih.gov/pubmed/21738572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0020347 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|